genedrive, the AIM-listed near patient molecular diagnostics company, has raised £6m in funding from new and existing equity investors through the issue of equity, loan notes and a broker option. The funding includes a £3.5m cornerstone i...
We use cookies to keep you signed in, remember your preferences and measure how the site is used. By continuing to browse Parsers VC you agree to that. Privacy & Terms
How would you rate Parsers VC?
On a scale from 1 to 10, how would you rate Parsers VC overall? It takes one click and helps us decide what to improve.
1 – poor10 – excellent
Thank you!
Your rating helps us make Parsers VC better.
Your rating was not saved
Something went wrong on our side. We will ask you again on one of your next visits.
Enjoying Parsers VC?
Thank you for rating Parsers VC so highly. Would you share your experience on G2? A short review helps other investors and founders find us.
